Annexon Stock Investor Sentiment

ANNX Stock  USD 5.14  0.03  0.58%   
Slightly above 64% of Annexon's investor base is looking to short. The analysis of the overall investor sentiment regarding Annexon suggests that many traders are alarmed. Annexon's investing sentiment can be driven by a variety of factors including economic data, Annexon's earnings reports, geopolitical events, and overall market trends.
  

Annexon Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Annexon can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
few days ago at simplywall.st         
Insiders Enjoy US903k Return After Buying Annexon Stock
Simply Wall St News at Macroaxis
few days ago at thelincolnianonline.com         
Annexon Trading Down 4.2 percent Should You Sell?
news
over a week ago at thelincolnianonline.com         
Analysts Set Annexon, Inc. Target Price at 15.80
news
over a week ago at gurufocus.com         
Biotechnology Value Fund L.P.s Strategic Acquisition of Annexon Inc Shares
Gurufocus Stories at Macroaxis
over a week ago at globenewswire.com         
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635
Macroaxis News: globenewswire.com
over a week ago at globenewswire.com         
Annexon Reports Third Quarter 2024 Portfolio and Financial Results, and Key Anticipated Milestones
Macroaxis News: globenewswire.com
over a week ago at thelincolnianonline.com         
Annexon vs. Acasti Pharma Critical Analysis
news
over a week ago at gurufocus.com         
FMR LLCs Strategic Acquisition of Annexon Inc Shares
Gurufocus Stories at Macroaxis
over a week ago at finance.yahoo.com         
Annexon Biosciences to Present at the Jefferies London Healthcare Conference
Yahoo News
over three weeks ago at www.macroaxis.com         
Disposition of 36050 shares by Love Douglas of Annexon at 1.8501 subject to Rule 16b-3
Macroaxis News
over a month ago at globenewswire.com         
Annexon Presents Phase 2 Vision Preservation Data with ANX007 in Dry AMD Patients with Less Advanced...
Macroaxis News: globenewswire.com
over a month ago at finance.yahoo.com         
Were Hopeful That Annexon Will Use Its Cash Wisely
Yahoo News
over a month ago at thelincolnianonline.com         
Ted Yednock Sells 5,408 Shares of Annexon, Inc. Stock
news
over a month ago at investing.com         
Annexon EVP Ted Yednock sells 40,073 in stock
Investing News at Macroaxis
over a month ago at finance.yahoo.com         
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635
Yahoo News
Far too much social signal, news, headlines, and media speculation about Annexon that are available to investors today. That information is available publicly through Annexon media outlets and privately through word of mouth or via Annexon internal channels. However, regardless of the origin, that massive amount of Annexon data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Annexon news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Annexon relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Annexon's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Annexon alpha.

Annexon Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of 5500 shares by Ted Yednock of Annexon at 5.64 subject to Rule 16b-3
09/05/2024
2
Disposition of 5500 shares by Ted Yednock of Annexon at 6.16 subject to Rule 16b-3
09/12/2024
3
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635
09/16/2024
4
Disposition of 4500 shares by Ted Yednock of Annexon at 7.1 subject to Rule 16b-3
09/19/2024
5
Annexon Trading Down 5.3 percent Following Insider Selling - MarketBeat
09/23/2024
6
Susquehanna Portfolio Strategies LLC Decreases Stake in Annexon, Inc. - MarketBeat
09/30/2024
7
Director William Carson Acquires 3,200 Shares of Annexon Inc
10/03/2024
8
Annexon to Present New Phase 2 ARCHER Data for ANX007 in Dry AMD Patients with Less Advanced GA at the American Academy of Ophthalmology 2024 Meeting
10/15/2024
9
Disposition of 36050 shares by Love Douglas of Annexon at 1.8501 subject to Rule 16b-3
10/30/2024
10
Annexon vs. Acasti Pharma Critical Analysis
11/14/2024
11
Biotechnology Value Fund L.P.s Strategic Acquisition of Annexon Inc Shares
11/15/2024
12
Insiders Enjoy US903k Return After Buying Annexon Stock
11/19/2024

Additional Tools for Annexon Stock Analysis

When running Annexon's price analysis, check to measure Annexon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annexon is operating at the current time. Most of Annexon's value examination focuses on studying past and present price action to predict the probability of Annexon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annexon's price. Additionally, you may evaluate how the addition of Annexon to your portfolios can decrease your overall portfolio volatility.